Antipsychotic Stewardship

GuideStar Eldercare's person-centered approach to pharmacology for residents with dementia and psychiatric conditions provides positive clinical outcomes for residents and support for LTC facilities. This program is backed by research published at AAIC 2022:

"Implementation of a shared cooperative clinical protocol between the SNF facility staff and clinical treatment team resulted in a reduction of antipsychotic use of more than 65% with no noted harms of clinical decline."

The GuideStar Eldercare Long-Term Care Antipsychotic Stewardship™ aims to reduce the usage of unnecessary medication by:

• Identifying appropriate diagnoses
• Polypharmacy review
• Gradual Dose Reduction (GDR) to provide indication or contraindication of reductions
• Thorough documentation via clinical notes from interprofessional healthcare team
• Education and guidance for facility staff on side effects, behaviors, and outcomes